Bioventus Inc.’s BVS surgical solutions business unit sales are expected to be in focus when the company reports its third-quarter 2023 results. Bioventus’ earnings beat estimates in one of the ...
BURRILLVILLE — An encore might be needed between Blackstone Valley School hockey and Burrillville/Ponaganset. It doesn’t have to be at Levy Rink, or any rink ...
Bioventus (BVS) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
It's amazing how a little tomorrow can make up for a whole lot of yesterday.”― John Guare. Today, we take a deeper look at a small medical device concern, whose stock has seen a huge recent surge.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
After helping his team win an epic four-overtime game against Lincoln to capture the Division II boys hockey championship on March 18, Colin Dorgan spoke about what it meant to return to the ice with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results